Sarcouncil Journal of Medicine and Surgery

Abstract: Background: Minimally invasive surgery in oncological gynecology has shown outstanding advances in technology, better postoperative morbidity rates, and subsequent quality of life. Objective: This paper was designed as a cross-sectional study that contributed to assessing and analyzing the clinical outcomes of minimally invasive surgery conducted on women with gynecologic malignancies. Patients and methods: We recruited 60 women, aged between 30 and 60 years, with malignant tumors. All demographic and clinical data and results of patients were collected from different hospitals in Iraq during the study period, which lasted from February 6, 2022, to September 17, 2023. The data included both surgical techniques and diagnostic techniques (CT and ultrasound), surgery time, blood flow rate, hospital stay, pain, complication rate, and quality of life. Results: Women were conducted with a with a surgical approach that consists of laparotomy surgery, which has 30 cases, and laparoscopy surgery, which has 30 cases. Diagnostic techniques used included CT scans of 39 women and ultrasounds of 21 women. The tumor size at patients who underwent laparotomy surgery was 5.4 ± 3.1 cm, and the and tumor size at patients who underwent laparotomy surgery was 15.1 ± 6.9 cm. The operative time was 223.80 ± 90.12 minutes for patients with laparotomy surgery and 215.23 ± 74.57 for patients with laparotomy surgery. Blood loss was 181.51 ± 119.84 mL for the laparoscopy surgery and 474.29 ± 390.56 in the laparotomy surgery, hospital stays were 4.7 ± 3.1 laparoscopy surgery and 8.9 ± 3.1 in the laparotomy surgery, intensive care unit admission was two women and mortality rate was 0% in the laparoscopy surgery while intensive care unit admission was four women and mortality rate was 16.67% in the laparotomy surgery, complications rate of laparoscopy surgery was five women while complications rate of laparoscopy surgery was 15 women, the most factors were infection, bleeding, and pain. Conclusion: Our current study demonstrated that minimally invasive surgery is the best and most effective treatment for gynecological malignancies, leading to improvements in women’s function and quality of life after surgery.